Moderna expects the Food and Drug Administration to make an approval decision on its next-generation Covid vaccine in late May. The company is also working to expand its RSV vaccine to people younger ...
Yet, uptake levels of vaccines in the US would tell a different story. As of mid-December, only 20.9 percent of adults in the ...